Buy or sell Akili Interactive Labs stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Akili Interactive Labs Stock
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games.
About Akili Interactive Labs Stock
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches. Akili’s cognitive engine enables three separate clinical game versions for remote data-capture, with features designed for patient engagement. Its proprietary adaptive mechanics allow the software to automatically personalize to the patient’s ability level with no clinician input required. Akili is based in Boston, Massachusetts.
Investors
Jazz Venture Partners
Pear Therapeutics, Akili Interactive Labs, Pymetrics, AllStripes, Halo Neuroscience
Funding History
January 2016 | $30.5M |
---|---|
July 2016 | $42.4M |
May 2018 | $55.0M |
Management
CEO
Eddie Martucci
Executive Creative Director
Matthew Omernick
Co-Founder
Adam Gazzaley
Executive Chairman
Robert Perez
Press
Boston Herald - Jun, 11 2018
FinSMEs (blog) - May, 9 2018
Xconomy - Dec, 5 2017
Business Insider - Dec, 4 2017
CNBC - Aug, 12 2017
- Jul, 20 2016
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase